Zhongzhi Pharmaceutical Holdings (HKSE:03737) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03737 Zhongzhi Pharmaceutical Holdings Ltd HKSE:03737
47 GF Score
Price HK$0.71
GF Value HK$0.89
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Zhongzhi Pharmaceutical Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Zhongzhi Pharmaceutical Holdings Valuation Rank Related Terms

HKSE:03737
47GF Score
Zhongzhi Pharmaceutical Holdings Ltd HKSE:03737
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhongzhi Pharmaceutical Holdings (HKSE:03737) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongzhi Pharmaceutical Holdings stock appears to be undervalued. The current stock price of HK$0.71 is trading 20.2% below its estimated GF Value™ of HK$0.89. GuruFocus considers Zhongzhi Pharmaceutical Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:03737:

  • Valuation Rank:
  • GF Value™: HK$0.89 vs. price of HK$0.71 (20.2% below fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the HKSE:03737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhongzhi Pharmaceutical Holdings Business Description

Address No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products in the PRC. The Group is a large industrial and trading enterprise group featuring researching, producing, and selling traditional Chinese medicine preparations, prepared slices of Chinese crude drugs, and foods. Its products include Shenqi Koufuye, Yinhuang Jiaonang, Yinhuang Keli, and others. Its segments are the pharmaceutical manufacturing segment, which generates maximum revenue, is engaged in the research and development, manufacturing, and sale of Chinese patent medicines and decoction pieces consisting of traditional decoction pieces and modern decoction pieces, and the operation of the chain pharmacies segment.
47GF Score

Get the complete analysis for HKSE:03737

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.71
Price
HK$0.89
GF Value